4.7 Article

1,2,4-Triazole-3-thione compounds with a 4-ethyl alkyl/aryl sulfide substituent are broad-spectrum metallo-β-lactamase inhibitors with re-sensitization activity

期刊

出版社

ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
DOI: 10.1016/j.ejmech.2021.113873

关键词

Metallo-beta-Lactamase inhibitor; 1,2,4-Triazole-3-thione; Bacterial resistance; beta-lactam antibiotic; Thioether

资金

  1. Agence Nationale de la Recherche [ANR-14-CE16-0028-01]
  2. Deutsche Forschungsgemeinschaft [BE1540/15-2, SPP 1710]
  3. Italian Ministry of Education, University and Research (MIUR)
  4. Agence Nationale de la Recherche (ANR) [ANR-14-CE16-0028] Funding Source: Agence Nationale de la Recherche (ANR)

向作者/读者索取更多资源

Metallo-beta-lactamases (MBLs) play a significant role in the resistance of Gram-negative bacteria to beta-lactam antibiotics. Researchers have explored compounds as broad-spectrum inhibitors of MBLs and found promising results in in vitro antibacterial susceptibility assays.
Metallo-beta-lactamases (MBLs) are important contributors of Gram-negative bacteria resistance to beta-lactam antibiotics. MBLs are highly worrying because of their carbapenemase activity, their rapid spread in major human opportunistic pathogens while no clinically useful inhibitor is available yet. In this context, we are exploring the potential of compounds based on the 1,2,4-triazole-3-thione scaffold as an original ligand of the di-zinc active sites of MBLs, and diversely substituted at its positions 4 and 5. Here, we present a new series of compounds substituted at the 4-position by a thioether-containing alkyl chain with a carboxylic and/or an aryl group at its extremity. Several compounds showed broad-spectrum inhibition with K-i values in the mu M to sub-mu M range against VIM-type enzymes, NDM-1 and IMP-1. The presence of the sulfur and of the aryl group was important for the inhibitory activity and the binding mode of a few compounds in VIM-2 was revealed by X-ray crystallography. Importantly, in vitro antibacterial susceptibility assays showed that several inhibitors were able to potentiate the activity of meropenem on Klebsiella pneumoniae clinical isolates producing VIM-1 or VIM-4, with a potentiation effect of up to 16-fold. Finally, a selected compound was found to only moderately inhibit the di-zinc human glyoxalase II, and several showed no or only moderate toxicity toward several human cells, thus favourably completing a promising behaviour. (C) 2021 Elsevier Masson SAS. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据